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Background
The ILAR classification of JIA represents a work in
progress. It has been suggested that patients with cluster-
ing features of early onset, female prevalence, asymmetric
arthritis, positive ANA, and risk of iridocyclitis constitute
a homogeneous entity, irrespective of the course of joint
disease.
Objective
To compare power of each clustering feature in identifying
a homogeneous disease subgroup in JIA.
Methods
All patients seen in study centers between 1983 and 2004
(N = 750) were classified according to ILAR criteria. Cate-
gories of systemic arthritis, RF-positive polyarthritis, and
enthesitis related arthritis were excluded because it was
felt they represent sufficiently homogeneous entities.
Patients in the remaining categories (oligoarthritis persist-
ent and extended, RF-negative polyarthritis, psoriatic
arthritis and undifferentiated arthritis) were grouped
together (N = 603). In each patient, the presence of the 6
clustering features was assessed. The relative power of
each clustering feature in identifying a homogeneous dis-
ease subgroup was examined by assessing its ability to
separate patients by the presence of the remaining cluster-
ing features.
Results
The ANA revealed the greatest power in separating
patients with or without the other clustering features (see
table 1), p < 0.01.
Conclusion
The ANA status revealed the strongest ability in identify-
ing the disease subgroup characterized by the presence of
clustering features. The optimal threshold for ANA posi-
tivity needs to be defined.
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Table 1: 
ANA Pos ANA Neg
Mean onset age (years) 3.9 6.8
Patients with onset age < 6 years (%) 81.3 45.9
Females (%) 80.0 68.8
Asymmetric arthritis at 6 months (%) 78.4 63.2
Iridocyclitis (%) 25.4 1.9